Page last updated: 2024-09-05

sb 203580 and prednisolone

sb 203580 has been researched along with prednisolone in 2 studies

Compound Research Comparison

Studies
(sb 203580)
Trials
(sb 203580)
Recent Studies (post-2010)
(sb 203580)
Studies
(prednisolone)
Trials
(prednisolone)
Recent Studies (post-2010) (prednisolone)
3,48941,13734,4143,3027,141

Protein Interaction Comparison

ProteinTaxonomysb 203580 (IC50)prednisolone (IC50)
Glucocorticoid receptorHomo sapiens (human)0.0278
Progesterone receptorHomo sapiens (human)2.08
Glucocorticoid receptorRattus norvegicus (Norway rat)0.0565
Glycine receptor subunit alpha-1Rattus norvegicus (Norway rat)0.016
Mineralocorticoid receptor Homo sapiens (human)0.0322
Glycine receptor subunit betaRattus norvegicus (Norway rat)0.016
Glycine receptor subunit alpha-2Rattus norvegicus (Norway rat)0.016
Glycine receptor subunit alpha-3Rattus norvegicus (Norway rat)0.016

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Henne, WA; Kularatne, SA; Low, PS; Santhapuram, HK; Vaitilingam, B; Venkatesh, C; Wang, K1
Beal, AM; Berger, SB; Bertin, J; Bury, MJ; Capriotti, CA; Casillas, LN; Charnley, AK; Convery, MA; Cook, MN; Cucchiara, S; Desai, BM; Finger, JN; Gough, PJ; Haile, PA; King, BW; Lakdawala, AS; Lipshutz, DB; MacDonald, TT; Mahajan, MK; Marquis, RW; Mehlmann, JF; Nagilla, R; Negroni, A; Ouellette, MT; Pierdomenico, M; Reilly, MA; Rivera, EJ; Singhaus, R; Stronati, L; Sun, HH; Swift, B; Totoritis, RD; Vossenkämper, A; Votta, BJ; Ziółkowski, B1

Other Studies

2 other study(ies) available for sb 203580 and prednisolone

ArticleYear
Synthesis and biological analysis of prostate-specific membrane antigen-targeted anticancer prodrugs.
    Journal of medicinal chemistry, 2010, Nov-11, Volume: 53, Issue:21

    Topics: Antigens, Surface; Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Drug Screening Assays, Antitumor; Glutamate Carboxypeptidase II; Glutarates; Humans; Ligands; Male; Molecular Targeted Therapy; Prodrugs; Prostatic Neoplasms; Structure-Activity Relationship; Urea

2010
The Identification and Pharmacological Characterization of 6-(tert-Butylsulfonyl)-N-(5-fluoro-1H-indazol-3-yl)quinolin-4-amine (GSK583), a Highly Potent and Selective Inhibitor of RIP2 Kinase.
    Journal of medicinal chemistry, 2016, 05-26, Volume: 59, Issue:10

    Topics: Aminoquinolines; Animals; Dose-Response Relationship, Drug; Female; Humans; Male; Mice; Mice, Inbred C57BL; Models, Molecular; Molecular Structure; Protein Kinase Inhibitors; Rats; Rats, Sprague-Dawley; Receptor-Interacting Protein Serine-Threonine Kinase 2; Structure-Activity Relationship; Sulfones

2016